BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7728147)

  • 1. Rapid nonradioactive assay for the detection of the common French Canadian tyrosinemia type I mutation.
    Grompe M; al-Dhalimy M
    Hum Mutat; 1995; 5(1):105. PubMed ID: 7728147
    [No Abstract]   [Full Text] [Related]  

  • 2. A single mutation of the fumarylacetoacetate hydrolase gene in French Canadians with hereditary tyrosinemia type I.
    Grompe M; St-Louis M; Demers SI; al-Dhalimy M; Leclerc B; Tanguay RM
    N Engl J Med; 1994 Aug; 331(6):353-7. PubMed ID: 8028615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations of the fumarylacetoacetate hydrolase gene in four patients with tyrosinemia, type I.
    Grompe M; al-Dhalimy M
    Hum Mutat; 1993; 2(2):85-93. PubMed ID: 8318997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency of the IVS12 + 5G-->A splice mutation of the fumarylacetoacetate hydrolase gene in carriers of hereditary tyrosinaemia in the French Canadian population of Saguenay-Lac-St-Jean.
    Poudrier J; St-Louis M; Lettre F; Gibson K; Prévost C; Larochelle J; Tanguay RM
    Prenat Diagn; 1996 Jan; 16(1):59-64. PubMed ID: 8821854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Six novel mutations in the fumarylacetoacetate hydrolase gene of patients with hereditary tyrosinemia type I.
    Timmers C; Grompe M
    Hum Mutat; 1996; 7(4):367-9. PubMed ID: 8723690
    [No Abstract]   [Full Text] [Related]  

  • 6. Type 1 hereditary tyrosinemia. Evidence for molecular heterogeneity and identification of a causal mutation in a French Canadian patient.
    Phaneuf D; Lambert M; Laframboise R; Mitchell G; Lettre F; Tanguay RM
    J Clin Invest; 1992 Oct; 90(4):1185-92. PubMed ID: 1401056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two novel mutations involved in hereditary tyrosinemia type I.
    St-Louis M; Poudrier J; Phaneuf D; Leclerc B; Laframboise R; Tanguay RM
    Hum Mol Genet; 1995 Feb; 4(2):319-20. PubMed ID: 7757089
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hereditary tyrosinemia type I].
    Endo F
    Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):130-3. PubMed ID: 9590006
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification of a stop mutation in five Finnish patients suffering from hereditary tyrosinemia type I.
    St-Louis M; Leclerc B; Laine J; Salo MK; Holmberg C; Tanguay RM
    Hum Mol Genet; 1994 Jan; 3(1):69-72. PubMed ID: 8162054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-induced correction of the genetic defect in tyrosinemia type I.
    Kvittingen EA; Rootwelt H; Berger R; Brandtzaeg P
    J Clin Invest; 1994 Oct; 94(4):1657-61. PubMed ID: 7929843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrum of mutations in the fumarylacetoacetate hydrolase gene of tyrosinemia type 1 patients in northwestern Europe and Mediterranean countries.
    Bergman AJ; van den Berg IE; Brink W; Poll-The BT; Ploos van Amstel JK; Berger R
    Hum Mutat; 1998; 12(1):19-26. PubMed ID: 9633815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fumarylacetoacetase mutations in tyrosinaemia type I.
    Rootwelt H; Høie K; Berger R; Kvittingen EA
    Hum Mutat; 1996; 7(3):239-43. PubMed ID: 8829657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyrosinemia type 1--complex splicing defects and a missense mutation in the fumarylacetoacetase gene.
    Rootwelt H; Kristensen T; Berger R; Høie K; Kvittingen EA
    Hum Genet; 1994 Sep; 94(3):235-9. PubMed ID: 8076937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different clinical forms of hereditary tyrosinemia (type I) in patients with identical genotypes.
    Poudrier J; Lettre F; Scriver CR; Larochelle J; Tanguay RM
    Mol Genet Metab; 1998 Jun; 64(2):119-25. PubMed ID: 9705236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pre- and post-natal diagnosis of tyrosinemia type I and the detection of the carrier state by assay of fumarylacetoacetase.
    Kvittingen EA; Brodtkorb E
    Scand J Clin Lab Invest Suppl; 1986; 184():35-40. PubMed ID: 3473612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hypertyrosinemia].
    Endo F
    Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):529-31. PubMed ID: 3270860
    [No Abstract]   [Full Text] [Related]  

  • 17. Simple detection of a (Finnish) hereditary tyrosinemia type 1 mutation.
    St-Louis M; Poudrier J; Tanguay RM
    Hum Mutat; 1996; 7(4):379-80. PubMed ID: 8723698
    [No Abstract]   [Full Text] [Related]  

  • 18. Mutations in the fumarylacetoacetate hydrolase gene causing hereditary tyrosinemia type I: overview.
    St-Louis M; Tanguay RM
    Hum Mutat; 1997; 9(4):291-9. PubMed ID: 9101289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two missense mutations causing tyrosinemia type 1 with presence and absence of immunoreactive fumarylacetoacetase.
    Rootwelt H; Chou J; Gahl WA; Berger R; Coşkun T; Brodtkorb E; Kvittingen EA
    Hum Genet; 1994 Jun; 93(6):615-9. PubMed ID: 8005583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tyrosinemia].
    Salo MK
    Duodecim; 1992; 108(9):841-3. PubMed ID: 1366298
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.